7/12 Rag-/- mice receiving OT-I T cells plus IL-7 therapy completely rejected EG7 lymphoma cells demonstrating that IL-7 therapy strongly enhances OT-I-dependent tumor rejection in our experimental system (Fig 1A). This evidence concerns the gene IL7 and lymphoma.